For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Menarini Silicon Biosystems, Inc.

USPTO Granted Patents = 30

CIPO Patents = 6

EPO Patents = 40

Trademarks = 15

Forward Citations = 49

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Nicolò Manaresi (19 out of 39 patents)

Gianni Medoro (18 out of 35 patents)

Alex Calanca (8 out of 11 patents)

4. Giuseppe Giorgini (5 out of 6 patents)

5. Mark Carle Connelly (4 out of 15 patents)

6. Brad Foulk (4 out of 5 patents)

7. Mélanie Abonnenc (3 out of 4 patents)

8. Denis Smirnov (3 out of 3 patents)

9. Galla Chandra Rao (3 out of 21 patents)

10. Michael T Kagan (2 out of 2 patents)

11. Joost F Swennenhuis (2 out of 3 patents)

12. Arjan G J Tibbe (2 out of 10 patents)

13. Karl Nielsen (2 out of 2 patents)

14. Leon W M M Terstappen (2 out of 25 patents)

15. John A Verrant (2 out of 12 patents)

30 patents: Sort by Forward Citations

1. 12153040 - Method for identification, selection and analysis of tumour cells (2024-11-26),

2. 12005450 - Method and apparatus for the reduction of the volume of a sample (2024-06-11),

3. 11921028 - Method and device for optical analysis of particles at low temperatures (2024-03-05),

4. 11859249 - Method and kit for the generation of DNA libraries for massively parallel sequencing (2024-01-02),

5. 11786900 - Microfluidic device, microfluidic system and method for the isolation of particles (2023-10-17),

6. 11567081 - Method of isolating circulating tumor cells (2023-01-31),

7. 11433403 - Electronic driving circuit for driving electrodes of a microfluidic device for manipulation of particles, and corresponding analysis apparatus (2022-09-06),

8. 11292001 - Microfluidic system and method for the recovery of particles (2022-04-05),

9. 11198902 - Methods and apparatus for the selection and/or processing of particles, in particular for the selective and/or optimised lysis of cells (2021-12-14),

10. 11077437 - Microfluidic system (2021-08-03),

11. 11015227 - Methods and compositions to generate unique sequence DNA probes, labeling of DNA probes and the use of these probes (2021-05-25),

12. 10945428 - Preservation of cellular components from cells with a preservative (2021-03-16),

13. 10895575 - Method for identification, selection and analysis of tumour cells (2021-01-19),

14. 10648897 - Method and apparatus for the identification and handling of particles (2020-05-12),

15. 10392657 - Method and kit for determining the genome integrity and/or the quality of a library of DNA sequences obtained by deterministic restriction site whole genome amplification (2019-08-27),

Menarini Silicon Biosystems S.p.A. is a leading biotech company specializing in the development of innovative technologies for rare cell biology isolation and characterization. With a focus on precision medicine, Menarini Silicon Biosystems offers a range of cutting-edge solutions that enable researchers and clinicians to capture, analyze, and molecularly characterize individual cells. Their advanced platforms are used in various fields, including liquid biopsy, oncology, reproductive health, and stem cell research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

30 Patents

#199 in San Diego, CA

#2,592 in California

#10,873 in US

#21,212 in the World

San Diego, CA, United States of America

Menarini Silicon Biosystems, Inc.

Forward Citations = 49

32 inventors:

Nicolò Manaresi (19 out of 39 patents)

Gianni Medoro (18 out of 35 patents)

Alex Calanca (8 out of 11 patents)

4. Giuseppe Giorgini (5 out of 6 patents)

5. Mark Carle Connelly (4 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…